Plasma Protein Biomarkers and Long‐Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart Disease
In patients with chronic coronary heart disease, biomarkers that reflect different pathophysiological pathways are associated with the risk of cardiovascular death for at least the next 15 years.
Authors
- Ian C. Marschner (ORCID: https://orcid.org/0000-0002-6225-1572)
- ANTHONY C. KEECH (ORCID: https://orcid.org/0000-0002-9426-9136)
- Leonard Kritharides (ORCID: https://orcid.org/0000-0001-5818-8024)
- Andrew Tonkin (ORCID: https://orcid.org/0000-0001-5291-0610)
- Ralph Stewart (ORCID: https://orcid.org/0000-0002-6167-1225)
- Tanja Zeller (ORCID: https://orcid.org/0000-0003-3379-2641)
- Kristy Pamela Robledo (ORCID: https://orcid.org/0000-0003-0213-7652)
- Harvey D. White (ORCID: https://orcid.org/0000-0001-7712-6750)
- Robert John Simes (ORCID: https://orcid.org/0000-0002-3740-7563)
- Gerald F. Watts (ORCID: https://orcid.org/0000-0003-2276-1524)
- Edward Janus (ORCID: https://orcid.org/0000-0002-0023-5710)
- Peter Thompson
Institutions
- The University of Sydney (AU)
- Universität Hamburg (DE)
- The University of Melbourne (AU)
- The University of Western Australia (AU)
- Royal Prince Alfred Hospital (AU)
- Concord Repatriation General Hospital (AU)
- Auckland City Hospital (NZ)
- University Medical Center Hamburg-Eppendorf (DE)
- Western Health (AU)
- German Centre for Cardiovascular Research (DE)
- Anzac Research Institute (AU)
- National Health and Medical Research Council (AU)
- Monash University (AU)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2024-10-25
- DOI
- https://doi.org/10.1161/jaha.123.034367
- Primary Topic
- Lipoproteins and Cardiovascular Health
- Type
- article
- Field-Weighted Citation Impact
- 0.00